Sciatica Treatment Without Surgery: What Mesa and East Valley Patients Should Know About Interventional Options

A 2025 evidence synthesis published in PMC analyzed 72 randomized controlled trials covering 7,701 patients and concluded that epidural steroid injections significantly relieve sciatica pain and improve function, outperforming other conservative treatments. For the up to 40% of Americans who will experience sciatica during their lifetime — according to StatPearls (NIH/National Library of Medicine) — this finding confirms what interventional pain specialists have observed clinically: that targeted, image-guided injections can provide meaningful relief when physical therapy, medications, and time alone fall short. At Arizona Pain and Spine Institute in Mesa, Dr. Asim Khan and Dr. Daniel Ryklin offer a full range of non-surgical sciatica treatments — from epidural steroid injections to nerve pain injections and radiofrequency ablation — designed to treat the source of sciatic nerve compression rather than simply masking the pain.

What Sciatica Actually Is — And Why It’s More Than “Just Back Pain”

Sciatica is one of the most commonly misused terms in medicine. As the StatPearls clinical reference (updated January 2024) notes, sciatica specifically refers to pain resulting from sciatic nerve or nerve root pathology — not simply any lower back pain or leg discomfort. The sciatic nerve, comprising nerve roots from L4 to S3, is the largest nerve in the human body, with a diameter of up to 2 centimeters. It runs from the lower spine through the buttocks and down each leg to the feet.

The epidemiology is striking. According to StatPearls, the lifetime incidence of sciatica is between 10% and 40%, with an annual incidence of 1% to 5%. Peak incidence occurs in the fourth decade of life (ages 30–40), and the condition rarely develops before age 20 unless caused by trauma. Occupational predisposition has been documented in machine operators, truck drivers, and workers whose jobs involve physically awkward positions.

A 2025 study published in Scientific Reports (Nature) examining 927 adults found a sciatica prevalence of 9.9%, with significant associations to arthritis, obesity, and family history. Perhaps most concerning, the study revealed that most participants demonstrated poor understanding of the condition’s causes and treatment options — suggesting that many people living with sciatica may not know that effective non-surgical treatments exist.

The Three Most Common Causes

Understanding what’s compressing or irritating the sciatic nerve is the first step toward effective treatment. The three primary causes are:

Lumbar disc herniation accounts for approximately 90% of sciatica cases. When the soft inner material of a spinal disc pushes through a tear in the outer layer, it can press directly on the adjacent nerve root. The most commonly affected levels are L4-L5 and L5-S1.

Lumbar spinal stenosis occurs when the spinal canal narrows, typically due to age-related degenerative changes, compressing the nerve roots. This is more common in patients over 60 and often causes symptoms that worsen with walking and improve with sitting.

Piriformis syndrome involves the piriformis muscle in the buttock tightening or spasming and compressing the sciatic nerve as it passes beneath or through the muscle. This accounts for a smaller but clinically significant percentage of cases.

Dr. Ryklin’s background in Physical Medicine and Rehabilitation — he is one of the few fellowship-trained pain physicians in the country with PM&R training — and his expertise in electrodiagnostic medicine (EMG/nerve conduction studies) make him particularly qualified to pinpoint which of these mechanisms is driving a patient’s symptoms. Accurate diagnosis is critical because the optimal treatment approach differs depending on the cause.

The Evidence for Non-Surgical Sciatica Treatment

The good news for sciatica patients is substantial: an estimated 80–90% of cases improve without surgery. The question is which non-surgical treatments deliver the most meaningful relief, and how quickly.

Epidural Steroid Injections: What 72 RCTs and 7,701 Patients Show

The most comprehensive evidence synthesis to date on epidural steroid injections (ESI) for sciatica was published in PMC in 2025 by Tsampoukos et al. The review analyzed 72 randomized controlled trials encompassing 7,701 patients and found that ESI significantly relieves pain and improves function in sciatica, outperforming other conservative treatments. The transforaminal approach appeared most effective among the three injection routes (interlaminar, transforaminal, and caudal).

A separate 2024 systematic review and meta-analysis published in Frontiers in Neurology by Zhang et al. specifically examined ESI for sciatica caused by lumbar disc herniation. This review found that epidural steroid injections demonstrated notable short-to-medium-term efficacy in pain relief and functional improvement. The analysis also revealed that ESI reduced opioid usage among treated patients — a clinically significant finding given the ongoing concerns about opioid dependence.

In February 2025, the American Academy of Neurology (AAN) published an updated systematic review in Neurology (Armon et al.) examining 90 randomized controlled trials. For cervical and lumbar radiculopathies, the review found that ESI probably reduces short-term pain, with a number needed to treat (NNT) of 4 — meaning that for every 4 patients treated, 1 achieves meaningful benefit beyond what would occur with placebo. While the AAN review noted that long-term efficacy is less established, it confirmed ESI’s role as a legitimate treatment option for radicular pain.

Important Nuances Patients Should Understand

The evidence consistently shows that epidural steroid injections are most effective in the short-to-medium term (up to 3 months), with diminishing benefit beyond 6 months. This doesn’t mean the treatment has failed — rather, it means ESI often serves as a bridge: providing relief during the acute inflammatory phase while the underlying disc herniation naturally resorbs (which occurs in a significant percentage of cases) or while the patient engages in physical therapy and rehabilitation.

As the 2025 PMC evidence synthesis noted, ESI was less effective than surgical intervention for long-term outcomes, but outperformed other non-surgical approaches. For the majority of sciatica patients — those who want to avoid surgery or who are not surgical candidates — ESI represents the strongest evidence-based interventional option available.

How Arizona Pain and Spine Institute Treats Sciatica

At Arizona Pain and Spine Institute, sciatica treatment follows a structured, evidence-based pathway at the practice’s Mesa, East Mesa, and Queen Creek locations.

Step 1: Comprehensive Diagnosis

The process begins with the practice’s thorough initial evaluation — which the practice states typically lasts 60 minutes or more. For sciatica specifically, this means identifying the precise source of nerve compression. Dr. Ryklin’s electrodiagnostic medicine expertise allows the practice to perform EMG and nerve conduction studies when needed, providing objective data about which nerve root is affected and the severity of compression. This matters because, as StatPearls notes, “a prevalent misconception often mislabels any low back pain or radicular leg pain as sciatica” — and treating the wrong diagnosis wastes time and money.

Imaging (typically MRI of the lumbar spine) confirms the structural cause — herniated disc, stenosis, or other pathology — and guides the treatment approach.

Step 2: Targeted Interventional Treatment

Based on the diagnosis, Dr. Khan and Dr. Ryklin select from a range of interventional options:

Lumbar epidural steroid injections deliver anti-inflammatory corticosteroid medication directly to the inflamed nerve root under fluoroscopic (live X-ray) guidance. The practice offers all three approaches documented in the literature — interlaminar, transforaminal, and caudal — selecting the optimal route based on the specific anatomy and location of nerve compression. As the practice’s published materials indicate, these procedures typically take 5 to 15 minutes and require no extended recovery.

Nerve pain injections target specific peripheral nerves contributing to the pain pattern. These selective nerve root blocks can serve a dual purpose: diagnostic (confirming which nerve root is the pain generator) and therapeutic (providing direct anti-inflammatory relief to the affected nerve).

Radiofrequency ablation (RFA) is an option for patients with chronic sciatica who have responded positively to diagnostic nerve blocks. RFA uses thermal energy to disrupt the pain signals from the affected nerves, providing longer-duration relief — typically 6 to 12 months — compared to steroid injections alone. The practice’s radiofrequency ablation capabilities provide an important escalation option for patients whose sciatica is refractory to injections.

Regenerative medicine offers a different mechanism of action for sciatica patients. The practice’s amniotic tissue biotechnology addresses the inflammatory and degenerative processes at the tissue level, rather than simply suppressing inflammation with steroids. This may be particularly relevant for disc-related sciatica, where the goal is to support disc healing rather than repeated symptom management.

Step 3: Multimodal Integration

Dr. Khan has emphasized that effective pain management requires multiple tools working together. For sciatica, this means the interventional treatments above are most effective when combined with targeted physical therapy (which Dr. Ryklin, given his PM&R background, frequently coordinates), activity modifications, and in some cases, complementary approaches. The practice’s comprehensive evaluation process ensures each patient receives an individualized plan rather than a one-size-fits-all approach.

What Patients Can Realistically Expect

Based on the published clinical evidence, sciatica patients at Arizona Pain and Spine Institute can expect:

Timeline for relief: The 2024 Frontiers in Neurology meta-analysis documented significant pain reduction and functional improvement at 6 weeks and 3 months following epidural steroid injection. Many patients report meaningful improvement within days to weeks of their first injection.

Success rates: The 2025 PMC evidence synthesis of 72 RCTs confirmed that ESI outperforms other conservative treatments for sciatica pain relief. The 2025 AAN systematic review reported a number needed to treat of 4 for short-term pain reduction — which means 1 in 4 patients achieves meaningful benefit over placebo.

Opioid reduction: The 2024 Frontiers in Neurology meta-analysis found that epidural steroid injections significantly reduced opioid usage among sciatica patients — an important benefit for patients seeking to avoid or reduce dependence on pain medications.

Duration of effect: ESI typically provides short-to-medium-term relief (weeks to months). For patients who need longer-duration relief, radiofrequency ablation can extend the benefit to 6–12 months. Regenerative medicine aims for even longer-term tissue-level healing.

Safety: The most common side effects of epidural steroid injections include temporary injection site discomfort, mild headache, and transient increases in blood sugar for diabetic patients. Serious complications are rare when the procedure is performed under fluoroscopic guidance by trained interventional pain specialists — which is the standard at Arizona Pain and Spine Institute.

When Surgery May Be Necessary

Non-surgical treatment is appropriate for the vast majority of sciatica patients, but certain situations warrant surgical evaluation. These include progressive neurological deficits (worsening muscle weakness or foot drop), cauda equina syndrome (loss of bowel or bladder control — a medical emergency), and sciatica that fails to improve after an adequate trial of interventional treatments. Arizona Pain and Spine Institute’s comprehensive evaluation process helps patients understand where they fall on this spectrum and when a surgical referral is appropriate.

How to Get Started

For sciatica patients in Mesa, Gilbert, Queen Creek, Chandler, Scottsdale, and Tempe, the pathway is straightforward:

1. Schedule a Consultation: Contact Arizona Pain and Spine Institute at (480) 986-7246 or visit gotpainarizona.com. The FastTrack cash-pay program is available for patients who need expedited access without insurance delays.
2. Bring Your Imaging: If you have a recent lumbar MRI, bring it to your appointment. If not, the practice can coordinate imaging. Dr. Ryklin may also recommend electrodiagnostic testing (EMG/NCS) to confirm the specific nerve root involvement.
3. Receive Your Individualized Plan: Based on the 60+ minute evaluation, Dr. Khan or Dr. Ryklin will recommend a treatment approach — which may include epidural steroid injection, nerve pain injection, RFA, regenerative medicine, or a combination — tailored to your specific diagnosis and goals.
4. Begin Treatment: Most interventional procedures at the practice are performed on an outpatient basis and take 5 to 15 minutes. Patients typically resume normal activities quickly.

Conclusion

The 72-RCT evidence synthesis covering 7,701 patients — combined with the AAN’s 90-RCT systematic review and the 2024 Frontiers in Neurology meta-analysis — provides the strongest evidence base yet assembled for non-surgical sciatica treatment. For the up to 40% of Americans who will experience sciatica, the data confirms that epidural steroid injections significantly relieve pain and improve function, reduce opioid usage, and outperform other conservative approaches.

Arizona Pain and Spine Institute’s combination of diagnostic precision (including Dr. Ryklin’s electrodiagnostic expertise), a full range of interventional treatments (ESI, nerve blocks, RFA, regenerative medicine), and an individualized multimodal approach positions the practice to deliver evidence-based sciatica care to patients across the East Valley. The next step is a conversation. Call (480) 986-7246 or schedule through gotpainarizona.com.

---

Frequently Asked Questions

1. How long does it take for a sciatica injection to work?

The 2024 Frontiers in Neurology meta-analysis documented significant pain reduction at 6 weeks. Many patients notice improvement within days of an epidural steroid injection, though full benefit typically develops over 1–2 weeks as inflammation subsides.

2. Can sciatica go away without treatment?

An estimated 80–90% of sciatica cases improve without surgery. However, the 2025 PMC evidence synthesis confirmed that epidural steroid injections accelerate recovery and outperform passive conservative management. Early intervention may prevent acute sciatica from becoming chronic.

3. How many epidural injections are needed for sciatica?

Treatment plans are individualized. Some patients achieve adequate relief with a single injection, while others benefit from a series of up to three injections spaced several weeks apart. Dr. Khan and Dr. Ryklin assess each patient’s response before recommending additional procedures.

4. Does Arizona Pain and Spine Institute accept insurance for sciatica treatment?

Yes, the practice accepts most insurance plans. For patients who need expedited access, the FastTrack cash-pay program provides appointments within days. Contact (480) 986-7246 for specific insurance questions.

5. What makes Arizona Pain and Spine Institute different for sciatica treatment?

The practice offers both diagnostic and interventional expertise under one roof. Dr. Ryklin’s fellowship-trained background in Physical Medicine and Rehabilitation includes electrodiagnostic medicine (EMG/nerve conduction studies), which provides objective data for precise diagnosis. The practice then offers a full range of treatments — ESI, nerve blocks, RFA, and regenerative medicine — rather than a single approach.

---

Disclaimer: This article references publicly available information from Arizona Pain and Spine Institute (gotpainarizona.com), StatPearls/National Library of Medicine (Davis et al., updated January 2024), Frontiers in Neurology (Zhang et al., 2024), PMC (Tsampoukos et al., 2025), Neurology/American Academy of Neurology (Armon et al., February 2025), Scientific Reports/Nature (2025), and ScienceDaily, including peer-reviewed systematic reviews, meta-analyses, clinical references, and published practice information dated 2020–2025. All metrics and study findings are from documented, peer-reviewed sources. The 2025 AAN systematic review noted that ESI efficacy for radiculopathy is primarily established in the short term, with limited evidence for long-term benefit. Results described are specific to the study populations and clinical settings mentioned and may vary based on individual patient circumstances, diagnosis, and treatment adherence. For current information about treatments offered at Arizona Pain and Spine Institute, consult gotpainarizona.com or call (480) 986-7246.